•1% EW reduced diarrhea incidence•Increase OM-specific IgE and IgA after 2 weeks of therapy but decrease IgE and IgA at the end of the study•Increase EW-specific IFNγ, IL-10 and Foxp3+ T cells. The gene discussed is FOXP3; the disease is ocular melanoma.